Spark Therapeutics is creating a path for advancements in hemophilia gene therapy research.

We are committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases. Learn more at www.sparktx.com

Be Informed. Feel Empowered.

Advance your knowledge of gene therapy research at HemophiliaForward.com

To connect with a representative from Spark Patient Advocacy email us at: patients@sparktx.com or contact a member our team at the conference:

Name	Phone	Email
Guillermo Campillo	720.364.6214	guillermo.campillo@sparktx.com
Tessa Field	267.595.9868	tessa.field@sparktx.com
Laureen Temple	267.250.2532	laureen.temple@sparktx.com

N-HEM-US-420086

Investigational Gene Therapy Clinical Study Participation

Gene Therapy Research and Its Potential Application for Hemophilia

Investigational Gene Therapy Research Studies For Hemophilia